UPDATED Sep 09, 2025
Discover small cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SIPHA | د.ت6.09 | 7.4% | 1.5% | د.ت11.0m | n/a | n/a | n/a | n/a | ||
ACR | AU$0.014 | 7.7% | -74.5% | AU$5.7m | n/a | PS4.8x | E121.1% | 0% | ||
CNSP | US$6.60 | 5.6% | -92.5% | US$3.8m | US$84.00 | PB0.3x | E-16.5% | n/a | ||
VAL | UK£0.0075 | 3.4% | -64.3% | UK£2.8m | n/a | PS56.4x | n/a | n/a | ||
MYND | CA$0.07 | 0% | n/a | CA$5.2m | n/a | PS5218346.4x | n/a | n/a | ||
BSFA | UK£0.022 | 2.3% | -41.3% | UK£2.8m | n/a | PS117.3x | n/a | n/a | ||
TOVX | US$0.40 | -1.8% | -89.7% | US$3.8m | US$7.00 | PB0.4x | E3.2% | n/a | ||
BBLG | US$2.15 | 1.4% | -67.5% | US$3.9m | US$22.50 | PB0.6x | n/a | n/a | ||
GRI | US$1.57 | 12.1% | -82.2% | US$3.9m | US$22.00 | PB1.2x | E-16.0% | n/a | ||
REVB | US$2.33 | -13.7% | -94.3% | US$4.0m | US$41.25 | PB1x | S74.4% | n/a | ||
EEP | €0.34 | 0% | -29.2% | €3.7m | n/a | PB0.6x | n/a | n/a | ||
GDR | UK£0.0047 | -9.5% | -78.9% | UK£3.0m | n/a | PS4.8x | n/a | n/a | ||
NYMX.F | US$0.043 | -12.2% | -57.0% | US$4.1m | n/a | PE-0.9x | n/a | n/a | ||
531521 | ₹80.97 | 0% | n/a | ₹359.4m | n/a | PE75x | n/a | n/a | ||
ATANA | SEK 0.02 | 0% | -75.0% | SEK 38.4m | n/a | PS6.2x | n/a | n/a | ||
RESP | SEK 7.72 | -12.5% | n/a | SEK 39.4m | n/a | PS23.2x | n/a | n/a | ||
A311960 | ₩1,995.00 | 38.3% | -33.4% | ₩5.8b | n/a | n/a | n/a | n/a | ||
540694 | ₹28.32 | 15.1% | -50.4% | ₹369.8m | n/a | PB0.6x | n/a | 0% | ||
JAGX | US$1.93 | 15.6% | -93.1% | US$4.2m | US$28.00 | PB0.8x | E71.8% | n/a | ||
XRTX | CA$1.12 | 1.8% | -59.6% | CA$5.8m | n/a | PB2.1x | n/a | n/a | ||
AYUR | CA$0.03 | 0% | -40.0% | CA$5.8m | n/a | PE-1.6x | n/a | n/a | ||
QPT | CA$0.035 | 0% | 40.0% | CA$5.9m | n/a | PB0.3x | n/a | n/a | ||
DHB | CA$0.19 | -5.0% | -24.0% | CA$5.9m | n/a | PB1.4x | E44.3% | n/a | ||
ONCO | US$2.78 | -5.1% | -99.3% | US$4.3m | n/a | PS3.2x | n/a | n/a |